4.2 Article

Personal Accounts of Australian Drug Discovery at the Public-Private Interface

期刊

AUSTRALIAN JOURNAL OF CHEMISTRY
卷 74, 期 1, 页码 16-27

出版社

CSIRO PUBLISHING
DOI: 10.1071/CH20244

关键词

-

资金

  1. ARC
  2. NHMRC
  3. Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS) program via Therapeutic Innovation Australia (TIA)

向作者/读者索取更多资源

The public-private interface in drug discovery is a dynamic stage that allows for higher risk but more rewarding research. Adequate resourcing is a perpetual challenge, but persistence, optimism, and flexibility can lead to a highly rewarding career. Selected examples in this account support this notion.
The public-private interface is a vibrant and invigorating stage for drug discovery and can allow for relatively higher risk but more rewarding research. Although adequate resourcing is a perennial challenge, persistence, optimism, and flexibility will pay dividends and can allow for a thoroughly rewarding career. In this account of chronological research experiences, selected examples are used to support this contention.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据